201 related articles for article (PubMed ID: 10416916)
21. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
[TBL] [Abstract][Full Text] [Related]
22. Acute dose range study of milrinone in congestive heart failure.
Kubo SH; Cody RJ; Chatterjee K; Simonton C; Rutman H; Leonard D
Am J Cardiol; 1985 Mar; 55(6):726-30. PubMed ID: 3976517
[TBL] [Abstract][Full Text] [Related]
23. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
[TBL] [Abstract][Full Text] [Related]
24. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
26. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
27. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
Nuñez S; Maisel A
Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093
[TBL] [Abstract][Full Text] [Related]
28. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
Cusick DA; Pfeifer PB; Quigg RJ
Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
[TBL] [Abstract][Full Text] [Related]
29. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
Cesario D; Clark J; Maisel A
Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R
J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
[TBL] [Abstract][Full Text] [Related]
33. Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias.
Holmes JR; Kubo SH; Cody RJ; Kligfield P
Am Heart J; 1985 Oct; 110(4):800-6. PubMed ID: 4050652
[TBL] [Abstract][Full Text] [Related]
34. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
35. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery.
Rathmell JP; Prielipp RC; Butterworth JF; Williams E; Villamaria F; Testa L; Viscomi C; Ittleman FP; Baisden CE; Royster RL
Anesth Analg; 1998 Apr; 86(4):683-90. PubMed ID: 9539583
[TBL] [Abstract][Full Text] [Related]
37. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
38. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
[TBL] [Abstract][Full Text] [Related]
39. Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart.
Piscione F; Jaski BE; Wenting GJ; Serruys PW
J Am Coll Cardiol; 1987 Dec; 10(6):1294-302. PubMed ID: 3680800
[TBL] [Abstract][Full Text] [Related]
40. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
